Process View
Any process that increases the rate or extent of cholesterol storage. Cholesterol storage is the accumulation and maintenance in cells or tissues of cholesterol, cholest-5-en-3 beta-ol, the principal sterol of vertebrates and the precursor of many steroids, including bile acids and steroid hormones.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "positive regulation of cholesterol storage"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| MED15 | mediator complex subunit 15 | 0.995 | ||
| DHCR7 | 7-dehydrocholesterol reductase | 0.710 | ||
| MAP2K3 | mitogen-activated protein kinase kinase 3 | 0.612 | ||
| INSIG1 | insulin induced gene 1 | 0.594 | ||
| MICALL1 | MICAL-like 1 | 0.546 | ||
| LDLR | low density lipoprotein receptor | 0.442 | ||
| HNF4A | hepatocyte nuclear factor 4, alpha | 0.407 | ||
| ANKFY1 | ankyrin repeat and FYVE domain containing 1 | 0.351 | ||
| RPL18A | ribosomal protein L18a | 0.312 | ||
| LSS | lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) | 0.296 | ||
| SQLE | squalene epoxidase | 0.244 | ||
| FADS1 | fatty acid desaturase 1 | 0.234 | ||
| SP1 | Sp1 transcription factor | 0.233 | ||
| SCD | stearoyl-CoA desaturase (delta-9-desaturase) | 0.186 | ||
| SMAD3 | SMAD family member 3 | 0.150 | ||
| MVD | mevalonate (diphospho) decarboxylase | 0.131 | ||
| TRIM11 | tripartite motif containing 11 | 0.111 | ||
| MDK | midkine (neurite growth-promoting factor 2) | 0.090 | ||
| SLC25A1 | solute carrier family 25 (mitochondrial carrier; citrate transporter), member 1 | 0.084 | ||
| HMGCS1 | 3-hydroxy-3-methylglutaryl-CoA synthase 1 (soluble) | 0.084 | ||
| SC4MOL | sterol-C4-methyl oxidase-like | 0.075 | ||
| LMNA | lamin A/C | 0.071 | ||
| DHCR24 | 24-dehydrocholesterol reductase | 0.062 | ||
| FDFT1 | farnesyl-diphosphate farnesyltransferase 1 | 0.061 | ||
| FASN | fatty acid synthase | 0.047 | ||
| STK10 | serine/threonine kinase 10 | 0.040 | ||
| MED25 | mediator complex subunit 25 | 0.039 | ||
| MED26 | mediator complex subunit 26 | 0.036 | ||
| PLEC | plectin | 0.035 | ||
| EHD4 | EH-domain containing 4 | 0.032 | ||
| CYP51A1 | cytochrome P450, family 51, subfamily A, polypeptide 1 | 0.031 | ||
| FOXO3 | forkhead box O3 | 0.029 | ||
| HTT | huntingtin | 0.028 | ||
| ZYX | zyxin | 0.027 | ||
| NCOA2 | nuclear receptor coactivator 2 | 0.026 | ||
| CREBBP | CREB binding protein | 0.024 | ||
| MLLT6 | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 6 | 0.024 | ||
| EFHD2 | EF-hand domain family, member D2 | 0.022 | ||
| MICAL1 | microtubule associated monoxygenase, calponin and LIM domain containing 1 | 0.020 | ||
| MAP7D1 | MAP7 domain containing 1 | 0.020 | ||
| LIPC | lipase, hepatic | 0.019 | Human | |
| APOA2 | apolipoprotein A-II | 0.019 | ||
| KIAA1377 | KIAA1377 | 0.019 | ||
| MAPKAPK2 | mitogen-activated protein kinase-activated protein kinase 2 | 0.019 | ||
| NFYC | nuclear transcription factor Y, gamma | 0.016 | ||
| APOA1 | apolipoprotein A-I | 0.016 | ||
| FABP4 | fatty acid binding protein 4, adipocyte | 0.016 | ||
| VASP | vasodilator-stimulated phosphoprotein | 0.015 | ||
| DEDD | death effector domain containing | 0.015 | ||
| BHMT | betaine--homocysteine S-methyltransferase | 0.014 | ||
| SLC2A2 | solute carrier family 2 (facilitated glucose transporter), member 2 | 0.014 | ||
| APOB | apolipoprotein B (including Ag(x) antigen) | 0.014 | ||
| FABP1 | fatty acid binding protein 1, liver | 0.014 | ||
| SCAP | SREBF chaperone | 0.014 | ||
| RIBC2 | RIB43A domain with coiled-coils 2 | 0.013 | ||
| UBE2Z | ubiquitin-conjugating enzyme E2Z | 0.013 | ||
| NCOA6 | nuclear receptor coactivator 6 | 0.012 | ||
| HAO1 | hydroxyacid oxidase (glycolate oxidase) 1 | 0.012 | ||
| LECT2 | leukocyte cell-derived chemotaxin 2 | 0.012 | ||
| KAT2B | K(lysine) acetyltransferase 2B | 0.012 | ||
| MBL2 | mannose-binding lectin (protein C) 2, soluble | 0.012 | ||
| MGAT1 | mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase | 0.012 | ||
| SERPINA6 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 6 | 0.011 | ||
| RAB11B | RAB11B, member RAS oncogene family | 0.011 | ||
| BAAT | bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase) | 0.011 | ||
| EPAS1 | endothelial PAS domain protein 1 | 0.011 | ||
| ELF4 | E74-like factor 4 (ets domain transcription factor) | 0.011 | ||
| FHL3 | four and a half LIM domains 3 | 0.011 | ||
| G6PC | glucose-6-phosphatase, catalytic subunit | 0.011 | ||
| RELB | v-rel reticuloendotheliosis viral oncogene homolog B | 0.011 | ||
| STARD4 | StAR-related lipid transfer (START) domain containing 4 | 0.010 | ||
| ACTN4 | actinin, alpha 4 | 0.010 | ||
| PROX1 | prospero homeobox 1 | 0.010 | ||
| AES | amino-terminal enhancer of split | 0.010 | ||
| MTTP | microsomal triglyceride transfer protein | 0.010 | ||
| CD163 | CD163 molecule | 0.010 | ||
| RELA | v-rel reticuloendotheliosis viral oncogene homolog A (avian) | 0.010 |